Biotech Values

[ghmm]

OMER:

I thought that too a while ago. They reworked their loan agreement where they can draw down the additional amounts without meeting the market cap requirement (though I believe they passed that with the recent surge).

IMO I think they should raise a good 100M or so to push the pipeline forward. I don't think Omidria will be able to sustain the company.